The pro-tumor effect exerted by S100A9 in oral cancer was in part via the increase of IL-6 expression and tumor infiltration of G-MDSCs although the involvement of other myeloid cell types and additional cytokines could not be ruled out. This evidence concerns the gene S100A9 and lip and oral cavity carcinoma.